Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients

被引：0
|
作者：
Martin Duracinsky
Pascale Leclercq
Susan Herrmann
Marie-Odile Christen
Marc Dolivo
Cécile Goujard
Olivier Chassany
机构：
[1] University Paris Diderot,Bicêtre Hospital, Internal Medicine and Clinical Immunology
[2] Sorbonne Paris Cité,Grenoble University hospital, Michallon hospital
[3] EA REMES,Institute for Immunology and Infectious Diseases
[4] Patient Reported Outcomes Unit,Department of Clinical Research
[5] Paris,undefined
[6] & AP-HP,undefined
[7] Information and Treatment Centres for Human Immunodeficiency,undefined
[8] BP 217,undefined
[9] Murdoch University,undefined
[10] Institut Behavior,undefined
[11] Association des Œuvres Sociales du Ministère des Affaires Etrangères,undefined
[12] Bicêtre Hospital,undefined
[13] Internal Medicine and Clinical Immunology,undefined
[14] & University Paris Sud,undefined
[15] University Paris Diderot,undefined
[16] Sorbonne Paris Cité,undefined
[17] EA REMES,undefined
[18] Patient Reported Outcomes Unit & AP-HP,undefined
[19] Saint-Louis Hospital,undefined
来源：
BMC Infectious Diseases | / 14卷
关键词：
HIV; Lipoatrophy; Poly-L-lactic acid; PLLA; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
  • [1] Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients
    Duracinsky, Martin
    Leclercq, Pascale
    Herrmann, Susan
    Christen, Marie-Odile
    Dolivo, Marc
    Goujard, Cecile
    Chassany, Olivier
    BMC INFECTIOUS DISEASES, 2014, 14
  • [2] Poly-L-lactic acid for facial lipoatrophy in HIV
    El-Beyrouty, Claudine
    Huang, Vanthida
    Darnold, Courtney J.
    Clay, Patrick G.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (09) : 1602 - 1606
  • [3] Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy
    Burgess, CM
    Quiroga, RM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) : 233 - 239
  • [4] Serial poly-L-lactic acid injections for the treatment of HIV-related facial lipoatrophy
    Ibrahim, S. F.
    Lampiris, H.
    Mauro, T.
    Southwell, H.
    Burt, C.
    Tien, P.
    Neuhaus, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S54 - S54
  • [5] Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy
    Moyle, GJ
    Brown, S
    Lysakova, L
    Barton, SE
    HIV MEDICINE, 2006, 7 (03) : 181 - 185
  • [6] Safety and efficacy of intradermal poly-L-lactic acid (Sculptra™) injections in patients with HIV-associated facial lipoatrophy
    Mest, DR
    Humble, G
    ANTIVIRAL THERAPY, 2004, 9 (06) : L36 - L37
  • [7] Poly-L-lactic acid for the treatment of trauma-induced facial lipoatrophy and asymmetry
    Rendon, Marta I.
    Keeling, Jon
    CUTIS, 2008, 81 (03): : 218 - 222
  • [8] Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients
    Borelli, C
    Kunte, C
    Weisenseel, P
    Thoma-Greber, E
    Korting, HC
    Konz, B
    SKIN PHARMACOLOGY AND PHYSIOLOGY, 2005, 18 (06) : 273 - 278
  • [9] Safety and efficacy of New-Fill® (Polylactic acid) in the treatment of HIV-associated lipoatrophy of the face (HALF)
    Engelhard, P
    Knies, M
    XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 365 - 367
  • [10] Efficacy and impact of retreatment with poly-L-lactic acid in persons with HIV-associated facial lipoatrophy
    Mest, Douglas R.
    Humble, Gail
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB34 - AB34
1234